MENU
donate

Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Pranela Rameshwar, PhD

Rutgers New Jersey Medical School
Presented in honor of Tami Bowling and METAvivors of NJ
Preventing epigenetic-mediated DNA repair induced by bone marrow niche cells to eliminate drug resistance
Abstract Report
Summary Report

Pranela Rameshwar, PhD

Rutgers University
Presented by METAvivor Facebook Fundraisers in honor of all people living with MBC
Towards precise treatment for metastatic breast cancer in black patients
Abstract Report
Summary Report

Shreyas Rao, PhD

The University of Alabama
Presented by Metavivor Facebook Fundraisers
Engineered biomimetic hydrogels to probe metastatic tumor cell cluster–brain microenvironment interactions facilitating tumor progression
Abstract Report
Summary Report

Sangeetha Reddy, MD, MSCI

University of Texas Southwestern Medical Center
Presented by MetGala Santa Clarita
Differential response to therapies stimulating antigen presentation by sites of metastases in triple negative breast cancer
Abstract Report

Angelina Regua, PhD

The University of Texas Health Science Center
Presented by Tonya’s Hope In Memory and Honor of Tonyia Lucas
Understanding and overcoming resistance of breast cancer brain metastases to RET inhibition
Abstract Report

Nathan Reticker-Flynn, PhD

Stanford University
Targeting lymph node-induced immune tolerance to treat metastatic breast cancer
Abstract Report
Summary Report

Isidore Rigoutsos, PhD

Sidney Kimmel Medical College, Thomas Jefferson University
Presented by METAvivor Fundraisers in honor of all people living with MBC
Short RNAs Promote Metastases in an Ancestry-dependent Manner
Abstract Report
Summary Report

Jennifer Rosenbluth, MD, PhD

University of California San Francisco
Presented in memory of Catherine Hill
Developing therapeutic strategies for metastatic inflammatory breast cancer using patient-derived organoids
Abstract Report
Summary Report

PARTHA ROY, PhD

University of Pittsburgh
Pharmacological Inhibition of Myocardin-Family Proteins as a Novel Strategy to Combat Metastatic Breast Cancer
Abstract Report

Davide Ruggero, PhD

University of California, San Francisco
Presented by the Minneapolis Metsquerade in memory of Erin Remme
Looking through a new lens: posttranscriptional regulation in metastatic breast cancer
Abstract Report

Davide Ruggero, PhD

University of California, San Francisco
Presented by METAvivor Fundraisers in honor of all people living with metastatic breast cancer
ERα is a novel RNA-binding protein controlling a post-transcriptional program underlying breast cancer metastasis
Abstract Report
Summary Report

Deepali Sachdev, BSc, MSc, PhD

Regents University
Presented by 2019 NYFW + #Cancerland in memory of Champagne Joy
Development of natural killer cell based tri-specific killer engagers (TriKEs) as novel immunotherapy for metastatic breast canc
Abstract Report
Summary Report
donate

SHOP  |  BLOG  |  CALENDAR

Facebook-f Instagram X-twitter Youtube Linkedin-in